title: Discontinuation of thioridazine in patients with learning disabilities: balancing cardiovascular toxicity with adverse consequences of changing drugs.
authors.affiliation: Psychopharmacology Unit, School of Medical Sciences, Bristol BS8 1TD, UK. simondavies@apexmail.com
authors.forename: Simon J C
authors.initials: SJ
authors.lastname: Davies
authors.forename: Leila B
authors.initials: LB
authors.lastname: Cooke
authors.forename: Alan G
authors.initials: AG
authors.lastname: Moore
authors.forename: John
authors.initials: J
authors.lastname: Potokar
mesh_terms: D014150:Antipsychotic Agents / Q000009:adverse effects*; D006801:Humans; D007859:Learning Disabilities / Q000188:drug therapy*; D007880:Legislation, Drug; D012307:Risk Factors; D013375:Substance Withdrawal Syndrome / Q000209:etiology; D013881:Thioridazine / Q000009:adverse effects*
chemical_list: D014150:Antipsychotic Agents; D013881:Thioridazine